Oncobiologics.com has Server used IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2010-07-18 (9 years, 116 days) and hosted in Chicago United States, server ping response time 26 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Oncobiologics keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Oncobiologics
2 Oncobiologics nj
3 Oncobiologics inc
4 Oncobiologics 10k
5 Oncobiologics ceo
6 Oncobiologics news
7 Oncobiologics jobs
8 Oncobiologics yahoo
9 Oncobiologics review

Hosting Provider

Website: Oncobiologics.com
Hostname: m28.siteground.biz
Region: IL
City: Chicago
Postal Code: 60661
Latitude: 41.882499694824
Longitude: -87.644096374512
Area Code: 312
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain

New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   Writemypaper4me.org (17 seconds ago)

   Automationminds.com (37 seconds ago)

   Jetporter.com (14 seconds ago)

   Oncobiologics.com (0 seconds ago)

   Ciaocucina.com (2 seconds ago)

   Ciaoeastchester.com (4 seconds ago)

   Titankey.com (8 seconds ago)

   Barka-fishing.com (7 seconds ago)

   Ny4.net (9 seconds ago)

   Theartofanesthesia.org (11 seconds ago)

   Shopreliable.com (44 seconds ago)

   Denispiel.com (4 seconds ago)

   Dentistinsacramento.com (3 seconds ago)

   Ciaoithaca.com (1 seconds ago)

   Ytsafe.com (6 seconds ago)

   Ciaopizzade.com (17 seconds ago)

   Galiciadigital.com (1 min ago)

   Ciao-pizza.com (20 seconds ago)

   5mgcialis-generic.com (2 seconds ago)

   Indiansmm.com (0 seconds ago)

Results For Websites Listing

Found 66 Websites with content related to this domain, It is result after search with search engine

Home - Outlook Therapeutics

JULY 16, 2019 Outlook Therapeutics Doses First Patient in the Second Phase 3 Clinical Trial for ONS-5010 in Wet AMD


Oncobiologics - Investor Overview | Outlook Therapeutics, Inc.

Corporate Profile. Outlook Therapeutics is a late clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a complex, technically challenging and commercially attractive monoclonal antibody, or mAb, for various ophthalmic indications.


Oncobiologics, Inc. (ONS) - Yahoo Finance

Oncobiologics, Inc. (ONS) (the “Company”) today announced several key corporate events that enhance the Company’s ability to advance the development of its lead product candidate, ONS-5010


Press Releases - Outlook Therapeutics, Inc.

CRANBURY, N.J. , Sept. 11, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”) today announced that it is scheduled to participate in the Ladenburg Thalmann 2019 Healthcare Conference being held at the Sofitel New York in New York on September 24 th .


Oncobiologics Inc. | LinkedIn

About us. OVERVIEW Oncobiologics is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics.


Working at Oncobiologics: Employee Reviews | Indeed.com

Oncobiologics is the type of place that fosters creativity and challenges your way of thinking. No day is typical, which also facilitates a great learning environment. Co-workers are like family member.


Oncobiologics, Inc. - OTLK - Stock Price Today - Zacks

View Oncobiologics, Inc. OTLK investment & stock information. Get the latest Oncobiologics, Inc. OTLK detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.


Oncobiologics Inc. - NASDAQ:ONS - Stock Quote & News

View detailed financial information, real-time news, videos, quotes and analysis on Oncobiologics Inc. (NASDAQ:ONS). Explore commentary on Oncobiologics Inc. and hear what the experts at TheStreet


Oncobiologics IPO: We Suggest Holding Off - Oncobiologics

Oncobiologics Incorporated (NASDAQ: ONS-OLD) expects to raise $53 million in its upcoming IPO. Based in Cranbury, New Jersey, Oncobiologics is a clinical stage biopharmaceutical company, focused


Recently Analyzed Sites